News Search Results
Aug 31, 2024, 04:50 ET Grit Biotechnology Receives U.S. FDA Clearance of Investigational New Drug Application for GT201, a genetically engineered TIL, following its Chinese IND Approval
SHANGHAI, Aug. 30, 2024 /PRNewswire/ -- Grit Biotechnology, a leading clinical-stage cell therapy company focusing on tumor-infiltrating lymphocyte (TIL) therapies, has achieved a major milestone with its
More news about: Grit Biotechnology
Aug 30, 2024, 17:46 ET Global Anti-Infective Drugs Market is Projected to Cross ~USD 175 Billion by 2030 | DelveInsight
Excision BioTherapeutics, TaiMed Biologics Inc., Gilead Sciences, ST Pharm Co., Ltd., Merck Sharp & Dohme LLC, Janssen Sciences Ireland UC, Vir Biotechnology, Inc., National Institute of Allergy and Infectious Diseases (NIAID), AbbVie, Sanofi, ModeX Therapeutics, among others.
More news about: DelveInsight Business Research, LLP
Aug 30, 2024, 16:50 ET Audiological Devices Market to Grow by USD 5.45 Billion from 2024 to 2028, Driven by Rising Hearing Loss Cases and AI's Influence on Market Trends - Technavio Report
Co. Ltd., Siemens Healthineers AG, Sonova AG, Starkey Laboratories Inc., WS Audiology AS, and ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD..
More news about: Technavio
Aug 30, 2024, 16:30 ET NeuroSense Therapeutics Announces Receipt of Nasdaq Minimum Bid Price Notification
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense" or the "Company"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that it has received a notification letter from the Nasdaq
More news about: NeuroSense
Aug 30, 2024, 16:15 ET AdvisorShares Announces Reverse Split of ETF
significant business activities in, or significant exposure to, the psychedelics industry including producers or distributors of psychedelic medicines, biotechnology companies engaged in research and development of psychedelic medicines, and companies that are part of the supply chain for psychedelics.
More news about: AdvisorShares
Aug 30, 2024, 16:00 ET AMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCE
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Aug 30, 2024, 12:30 ET ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™
founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology company that develops innovative scientific instruments based on integrated, multidisciplinary technologies to enable life science research, diagnostics,
More news about: ThinkCyte Inc.
Aug 30, 2024, 06:00 ET Breaking News | Sanyou Bio Launches Comprehensive Monkeypox Product Line
to global public health. About Sanyou Biopharmaceuticals Sanyou Biopharmaceuticals Co., Ltd. is a world-leading high-tech biotechnology enterprise focusing on R&D and services of innovative biologic drugs. Sanyou has built the 4C business patterns that integrate "differentiated
More news about: Sanyou Bio
Aug 29, 2024, 17:40 ET The Solvents Market is projected to expand by USD 9.6 billion from 2024-2028, driven by advances in solvent recovery and recycling technologies, AI's impact on reshaping the market landscape- Technavio report
production of various chemicals. The market is also witnessing a shift towards eco-friendly and organic solvents due to growing environmental concerns. Biotechnology firms are exploring the use of solvents in the production of deicers, cooling circuits, and dry cleaning. The beauty industry, including skin care
More news about: Technavio
Aug 29, 2024, 17:31 ET Global Vaccine Adjuvants Market to Show Remarkable Growth at a CAGR of ~13% by 2030 | DelveInsight
May 2023 Croda International Plc entered into a partnership with Amyris and Botanical Solutions Inc. firstly for biotechnology-derived squalene and secondly with BSI to develop a sustainable QS-21 vaccine adjuvant moving towards plant tissue culture-derived approach rather
More news about: DelveInsight Business Research, LLP
Aug 29, 2024, 16:05 ET Congruence Therapeutics Announces Participation in Upcoming Investor Conferences
Aug. 29, 2024 /PRNewswire/ -- Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of correctors for diseases of protein misfolding, including MC4R-deficient genetic obesity, GBA-driven Parkinson's
More news about: Congruence Therapeutics
Aug 29, 2024, 16:05 ET REGENXBIO to Participate in Upcoming Investor Conferences
available for approximately 30 days following the presentation. ABOUT REGENXBIO Inc. REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development
More news about: REGENXBIO Inc.
Aug 29, 2024, 16:01 ET Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options
Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that it has completed its previously announced non-brokered private placement offering of 5,025,725 units of
More news about: Innocan Pharma Corporation
Aug 29, 2024, 16:00 ET AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Aug 29, 2024, 14:55 ET Calibration Services Market to Grow by USD 1.79 Billion from 2024-2028, Strict Regulations on Product Safety, Quality, and Compliance Drive Growth, Report Highlights AI's Impact on Market Dynamics - Technavio
network analyzers, power analyzers, and voltage meters. Sectors like aerospace, manufacturing, energy and utilities, electronics manufacturing, biotechnology, and military are major consumers of calibration services. Services offered include electrical and mechanical calibration, thermodynamic calibration,
More news about: Technavio
Aug 29, 2024, 10:32 ET Nikon Announces New Image Analysis Functions to Empower Drug Discovery Research for Cancer, Neurological Disease, and Regenerative Medicine
changes over time are added to certain pre-existing assays to enable more advanced experiments. This update will assist research institutions, biotechnology companies, and organizations engaged in drug discovery research and development in efficiently capturing and analyzing complex cellular responses
More news about: Nikon Instruments Inc.
Aug 29, 2024, 09:51 ET Unlock the Full Potential of Cell and Gene Therapies: The 2024 GenScript Biotech Global Forum Heads to London
rising. These therapies are demonstrating substantial application potential, establishing themselves as one of the most promising frontiers in global biotechnology. In addition to the surge in approvals, 2024 has seen notable advancements in CGT technologies. Atara Biotherapeutics' off-the-shelf T cell
More news about: GenScript Biotech Corporation
Aug 29, 2024, 09:03 ET Virax Biolabs to Participate at 7th European Congress of Immunology
Aug. 29, 2024 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today it will be hosting a booth at the
More news about: Virax Biolabs
Aug 29, 2024, 08:05 ET Rigel to Participate in Upcoming September Investor Conferences
Aug. 29, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Dean Schorno, the company's chief financial
More news about: Rigel Pharmaceuticals, Inc.
Aug 29, 2024, 08:00 ET BioMarin to Present at the 22nd Annual Morgan Stanley Global Healthcare Conference on Thursday, September 5 at 7:45 AM PT / 10:45 AM ET in New York, NY
through the Company's website for a limited time following the conference. About BioMarin Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root
More news about: BioMarin Pharmaceutical Inc.
Aug 29, 2024, 08:00 ET Flamingo Therapeutics Announces Participation in Upcoming Investor Conferences
undruggable transcription factors and long non-coding RNAs. Flamingo has an alliance with Ionis Pharmaceuticals and is supported by well-known biotechnology investors including Abrdn (formerly funds managed by Tekla Capital Management LLC), Andera Partners, Bpifrance Large Venture, Bpifrance through
More news about: Flamingo Therapeutics
Aug 29, 2024, 06:59 ET Q32 Bio to Participate in Upcoming September Investor Conferences
Aug. 29, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that management will participate in three upcoming
More news about: Q32 Bio
Aug 29, 2024, 01:27 ET Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan
international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian and global biotechnology and pharmaceuticals industries, changes in political conditions in India
More news about: Biocon Biologics Ltd.
Aug 29, 2024, 01:13 ET Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan
international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian and global biotechnology and pharmaceuticals industries, changes in political conditions in India
More news about: Biocon Biologics Ltd.
Aug 28, 2024, 18:26 ET Activation Capital Selects 10 Startups for Inaugural Frontier BioHealth Program
medical device, and health-focused consumer products companies. As an independent nonprofit corporation operating on behalf of the Virginia Research Biotechnology Partnership Authority, Activation Capital is committed to advancing life sciences and other cutting-edge technologies through scientific research,
More news about: Activation Capital